Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Glerum PJ"'
Autor:
Glerum PJ; Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Yamada WM; Laboratory of Applied Pharmacokinetics and Bioinformatics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA., Neely MN; Laboratory of Applied Pharmacokinetics and Bioinformatics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA., Burger DM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands., Maliepaard M; Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands., Neef C; Department of Clinical Pharmacy and Toxicology, CARIM, Maastricht University, Maastricht, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Jul; Vol. 90 (7), pp. 1576-1585. Date of Electronic Publication: 2023 Feb 02.
Autor:
Glerum PJ; Medicines Evaluation Board, CBG-MEB, P.O. Box 8275, 3503 GB, Utrecht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands., Neef C; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands., Burger DM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands., Yu Y; Medicines Evaluation Board, CBG-MEB, P.O. Box 8275, 3503 GB, Utrecht, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands., Maliepaard M; Medicines Evaluation Board, CBG-MEB, P.O. Box 8275, 3503 GB, Utrecht, The Netherlands. m.maliepaard@cbg-meb.nl.; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands. m.maliepaard@cbg-meb.nl.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2020 Sep; Vol. 59 (9), pp. 1065-1069.
Autor:
Glerum PJ; Medicines Evaluation Board, P.O. Box 8275, 3503 GB, Utrecht, The Netherlands. pieter.glerum@maastrichtuniversity.nl.; Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands. pieter.glerum@maastrichtuniversity.nl., Maliepaard M; Medicines Evaluation Board, P.O. Box 8275, 3503 GB, Utrecht, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands., de Valk V; National Health Care Institute, Diemen, The Netherlands., Burger DM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands., Neef K; Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Publikováno v:
BMC health services research [BMC Health Serv Res] 2020 Jul 13; Vol. 20 (1), pp. 650. Date of Electronic Publication: 2020 Jul 13.
Autor:
Karres D; European Medicines Agency, Amsterdam, The Netherlands., Ali S; European Medicines Agency, Amsterdam, The Netherlands., van Hennik PB; Committee for Medicinal Products for Human Use (CHMP), Amsterdam, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands., Straus S; Pharmacovigilance Risk Assessment Committee (PRAC), Amsterdam, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands., Josephson F; Committee for Medicinal Products for Human Use (CHMP), Amsterdam, The Netherlands.; Department of Efficacy and Safety 3, Medical Products Agency, Uppsala, Sweden., Thole G; Medicines Evaluation Board, Utrecht, The Netherlands., Glerum PJ; Medicines Evaluation Board, Utrecht, The Netherlands., Herberts C; Medicines Evaluation Board, Utrecht, The Netherlands., Babae N; Medicines Evaluation Board, Utrecht, The Netherlands., Herold R; European Medicines Agency, Amsterdam, The Netherlands., Papadouli I; European Medicines Agency, Amsterdam, The Netherlands., Pignatti F; European Medicines Agency, Amsterdam, The Netherlands.
Publikováno v:
The oncologist [Oncologist] 2020 Jun; Vol. 25 (6), pp. e976-e981. Date of Electronic Publication: 2020 Mar 10.
Autor:
Glerum PJ; Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands., Maliepaard M; Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands., de Valk V; National Health Care Institute, Diemen, The Netherlands., Scholl JHG; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., van Puijenbroek EP; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.; Pharmaco-Therapy, Epidemiology, and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands., Burger DM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands., Neef K; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2020 May; Vol. 13 (3), pp. 599-607. Date of Electronic Publication: 2020 Feb 12.
Autor:
Glerum PJ; Medicines Evaluation Board, Utrecht, the Netherlands.; Department of Epidemiology, CAPHRI, Maastricht University, the Netherlands., Yu Y; Medicines Evaluation Board, Utrecht, the Netherlands., Yamada WM; Laboratory of Applied Pharmacokinetics and Bioinformatics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA., Neely MN; Laboratory of Applied Pharmacokinetics and Bioinformatics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA., Maliepaard M; Medicines Evaluation Board, Utrecht, the Netherlands., Burger DM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, the Netherlands., Neef C; Department of Clinical Pharmacy and Toxicology, CARIM, Maastricht University, the Netherlands.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2018 Nov; Vol. 104 (5), pp. 966-973. Date of Electronic Publication: 2018 Feb 13.